Autres langues Infinity Pharmaceuticals, Inc.

Actions

INFI.Q

US45665G3039

Services et équipements environnementaux

Cours en clôture OTC Markets 30/09/2026			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	-.--%		-.--%	-

25/03/24	Infinity Pharmaceuticals, Inc. a cessé ses activités	CI
15/02/24	Une société d'investissement inconnue dans le secteur de la santé a acquis la quasi-totalité des actifs d'Infinity Pharmaceuticals, Inc. (OTCPK:INFI.Q).	CI

Autres langues

14/05/24	Triple Negative Breast Cancer Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
25/03/24	Infinity Pharmaceuticals, Inc. Went Out of Business
07/03/24	Revised Liquidation Plan Approved for Infinity Pharmaceuticals, Inc.
22/02/24	Motion for Di Minimis Assets Sale Approved for Infinity Pharmaceuticals, Inc.
15/02/24	An unknown healthcare investment firm acquired Substantially all of the assets of Infinity Pharmaceuticals, Inc. (OTCPK:INFI.Q).
13/02/24	First Motion for Exclusivity Period Extension Approved For Infinity Pharmaceuticals, Inc.
01/02/24	Disclosure Statement Approved on Interim Basis for Infinity Pharmaceuticals, Inc.
26/01/24	First Motion for Exclusivity Period Extension Filed by Infinity Pharmaceuticals, Inc.
11/01/24	Joint Liquidation Plan and Disclsoure Statement Filed by Infinity Pharmaceuticals, Inc.
08/01/24	Motion for Asset Sale Approved for Infinity Pharmaceuticals, Inc.
05/12/23	Triple Negative Breast Cancer Pipeline, FDA Approvals, Clinical Trials Assessment, Companies 2023 \| Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., and others.
23/10/23	Bidding Procedure Approved for Infinity Pharmaceuticals, Inc.
02/10/23	Motion for Joint Administration Approved for Infinity Pharmaceuticals, Inc.
30/09/23	Infinity Pharmaceuticals : Bankruptcy - Form 8-K
29/09/23	Infinity Pharmaceuticals, Inc. Announces Resignation of Adelene Perkins from the Board
29/09/23	INFINITY PHARMACEUTICALS LISTS BOTH ESTIMATED ASSETS AND LIABILI…
29/09/23	Motion for Asset Sale Filed by Infinity Pharmaceuticals, Inc.
29/09/23	Motion for Joint Administration Filed by Infinity Pharmaceuticals, Inc.
29/09/23	Infinity Pharmaceuticals, Inc. Filed for Bankruptcy
18/09/23	Infinity Pharmaceuticals, Inc.(OTCPK:INFI) dropped from S&P TMI Index
13/09/23	Infinity Pharmaceuticals Shares Fall Ahead of Expected Suspension From Nasdaq Trading on Sept. 14
13/09/23	Infinity Pharmaceuticals, Inc.(OTCPK:INFI) dropped from NASDAQ Composite Index
01/09/23	Infinity Pharmaceuticals, Inc. Announces Resignation of Robert Ilaria, Jr., M.D., as Chief Medical Officer
01/09/23	Infinity Pharmaceuticals, Inc. Announces Chief Executive Officer Changes
19/08/23	INFINITY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm